Beijing, China

Defang Liu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2024

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: The Innovative Contributions of Inventor Defang Liu

Introduction: Defang Liu, based in Beijing, China, stands out as a prolific inventor in the field of medical technology. With two patents to his name, Liu has made significant strides in cancer treatment and cell reprogramming, reflecting his commitment to advancing the scientific landscape.

Latest Patents: Liu’s latest innovations include two notable patents. The first, titled "Composition for Treating Cancer and Use and Medicament Thereof," focuses on a combination of an SGLT1 inhibitor and a VEGFR2 inhibitor. This groundbreaking composition highlights the interaction between SGLT1 and VEGFR2 in tumor development and progression, showcasing a synergistic anti-tumor effect that promises new avenues for cancer therapy. The second patent, "Methods for Chemically Induced Lineage Reprogramming," introduces chemical inducers of lineage reprogramming, facilitating the transformation of partially or completely differentiated cells into cells of different lineages. This method presents immense potential for regenerative medicine.

Career Highlights: Defang Liu has contributed to significant research during his career, specifically with institutions such as the Beihao Stem Cell and Regenerative Medicine Research Institute and Hong Guan Ltd. His work continues to attract attention for its impact on medical technology, particularly in cancer treatment and cellular reprogramming.

Collaborations: Liu has collaborated with esteemed colleagues such as Hongkui Deng and Jing Li, who have also made substantial contributions in their respective fields. Their partnerships reflect a shared drive for innovation and excellence in medical research.

Conclusion: As an inventor, Defang Liu exemplifies the spirit of innovation. His patents address critical challenges in cancer treatment and cellular biology, making him a noteworthy figure in contemporary scientific research. With continued collaboration and development, Liu’s work promises to enhance medical technology and improve patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…